176 related articles for article (PubMed ID: 38327651)
21. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
PeerJ; 2019; 7():e7816. PubMed ID: 31608178
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
23. SAA1 identified as a potential prediction biomarker for metastasis of hepatocellular carcinoma
Li G; Shen Q; Xu H; Zhou Y; Li C; Li Y; He M
Front Oncol; 2023; 13():1138995. PubMed ID: 37081987
[TBL] [Abstract][Full Text] [Related]
24. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
26. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
[TBL] [Abstract][Full Text] [Related]
27. Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation.
Ma H; Li Z; Yuan J; Zhang L; Xie X; Yin X; Chen R; Ren Z
Gastroenterol Res Pract; 2021; 2021():8878417. PubMed ID: 33488700
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma.
Wang M; Qiu ZH; Wang YZ; Lian B; Bai JK; Zhou YJ; Ji HJ
BMC Cancer; 2023 Jan; 23(1):19. PubMed ID: 36609254
[TBL] [Abstract][Full Text] [Related]
29. Expression of E-cadherin and vascular endothelial growth factor in noncancerous liver is associated with recurrence of hepatocellular carcinoma after curative resection.
Minata M; Kudo M; Harada KH; Ikai I; Nishida N
Oncology; 2013; 84 Suppl 1():88-92. PubMed ID: 23428865
[TBL] [Abstract][Full Text] [Related]
30. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
31. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
32. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
33. Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma.
Wang J; Liu F; Ao P; Li X; Zheng H; Wu D; Zhang N; She J; Yuan J; Wu X
Onco Targets Ther; 2016; 9():5597-602. PubMed ID: 27672330
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of Nectin-4 in hepatocellular carcinoma.
Ma J; Sheng Z; Lv Y; Liu W; Yao Q; Pan T; Xu Z; Zhang C; Xu G
Onco Targets Ther; 2016; 9():183-90. PubMed ID: 26793002
[TBL] [Abstract][Full Text] [Related]
35. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
Gong Y; Wei ZR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
[TBL] [Abstract][Full Text] [Related]
36. ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection.
Hwang HW; Ha SY; Bang H; Park CK
Cancer Res Treat; 2015 Oct; 47(4):853-61. PubMed ID: 25687855
[TBL] [Abstract][Full Text] [Related]
37. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
38. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
40. A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma.
Liang XY; Zhang Y; He YN; Liu XY; Ding ZH; Zhang XD; Dong MY; Du RL
Front Genet; 2022; 13():888601. PubMed ID: 36171884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
